AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?

The latest scientific knowledge has provided additional insights accountable for the worst prognosis for pancreatic ductal adenocarcinoma (PDAC). Among the causative factors, the aptitude to develop resistance towards approved medications denotes the master key for understanding the lack of improvem...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapio, Luigi, Ragone, Angela, Spina, Annamaria, Salzillo, Alessia, Naviglio, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511794/
https://www.ncbi.nlm.nih.gov/pubmed/36176754
http://dx.doi.org/10.20517/cdr.2022.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511794/
https://www.ncbi.nlm.nih.gov/pubmed/36176754
http://dx.doi.org/10.20517/cdr.2022.34

Ejemplares similares